Visceral adiposity comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
In response to Estadão, the Ministry of Communications released a statement with its position regarding the trip. The statement affirms that the minister had official commitments during the trip to the state of São Paulo:The minister fulfilled an official agenda on 26 and 27 January, participating in meetings with the operator Claro, where the company's investment plan in the country was presented; [he also participated in] a technical meeting with the team of the regional office of the affiliated Telebrás; a meeting with the regional manager of the affiliated agency Anatel; and [participated in] a visit and meeting with the BYD group in SP.In an exclusive interview with journalist Reinaldo Azevedo on BandNews FM, Lula declared:I tried this week to talk with Juscelino; minister Juscelino is traveling, he is abroad on ministry business discussing at the telecommunications meeting. I have already asked minister Rui Costa to summon him for Monday so that we can have a conversation because he has the right to prove his innocence, but if he cannot prove his innocence he cannot remain in the government. I guarantee everyone the presumption of innocence.Pressured by allies and opponents regarding the permanence or dismissal of the minister, the president met with Juscelino on 6 March to demand explanations from him regarding the accusations. After the meeting, Lula decided to keep the minister. On his official Twitter profile, Juscelino published:I have just left the Palácio do Planalto, where I had a very positive meeting with president Lula.
==== Other drugs ==== Acamprosate (Alcomed; Aotal; calcium acetylhomotaurinate; Campral; Campral EC; NS-11; Regtect; Sobriol; Zulex) – various actions – alcoholism Baclofen (Baclocur) – GABAB receptor agonist – alcoholism Calcium carbimide (Temposil) – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Cyanamide – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Disulfiram (Antabuse, Antabus) – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism Flumazenil (flumazepil; Anexate) – GABAA receptor negative allosteric modulator/benzodiazepine antidote – benzodiazepine overdose Lofexidine (BA-168; BritLofex; Lucemyra; MDL-14042; MDL-14042A; RMI-14042A) – α2-adrenergic receptor agonist – opioid-related disorders Sodium oxybate (Alcover; SMO immediate release formulation) – GABAB and GHB receptor agonist – alcoholism
The research was continued by Lehmann who started a systematic study, first of cholesteryl benzoate, and then of related compounds which exhibited the double-melting phenomenon. He was able to make observations in polarized light, and his microscope was equipped with a hot stage (sample holder equipped with a heater) enabling high temperature observations. The intermediate cloudy phase clearly sustained flow, but other features, particularly the signature under a microscope, convinced Lehmann that he was dealing with a solid. By the end of August 1889 he had published his results. Lehmann's paper prompted work by Ludwig Gattermann who in 1890 published a paper on the synthesis of azoxyphenol ethers, such as para-azoxyanisole, which exhibited the same double-melting behaviour. Lehmann's interpretation of his results was controversial, and was not accepted by Gustav Heinrich Tammann, Georg Hermann Quincke, and Walther Nernst. In 1905 research by Rudolf Schenck addressed and largely resolved the objections of Tamman, Quincke and Nernst. Lehmann's work was continued and significantly expanded by the German chemist Daniel Vorländer who from the beginning of the 20th century had synthesized most of the liquid crystals known. In 1910–1922 research on liquid crystals, led by Georges Friedel, was carried on in France. In the period before X-rays liquid crystals were seen as merely a curiosity by scientists, and the field did not yield applications until the second half of the 20th century.
=== 2 February === According to a South Korean news report, North Korea was planning to send up to 500 military and police personnel to Russian-occupied Donbass after pulling back on a previous plan to send workers. Police stated that a Russian missile destroyed an apartment building in Kramatorsk, killing at least three people and injuring 20 others. EU officials visited Kyiv.
Sources: en.wikipedia.org
==== Tensile strength ==== The tensile strength of a material quantifies how much elongating stress the material will endure before failure. This is very important in applications that rely upon a polymer's physical strength or durability. For example, a rubber band with a higher tensile strength will hold a greater weight before snapping. In general, tensile strength increases with polymer chain length and crosslinking of polymer chains.
Belize led to a request for assistance from the International Organization for Migration (IOM) in 2016, which led to the 2018 launch of a national migration policy plan. Most migrants enter Belize with intentions to cross into the US, and as of 2018, migrants made up 15% of Belize's population. Emigration from Belize has tended to be concentrated on the United States, and sometimes Canada or other English-speaking countries. The majority of immigrants to Belize are from other Central American countries like Nicaragua, El Salvador, and Honduras, as Belize has a fairly welcoming immigration policy to help these newcomers assimilate. Belizeans have historically moved to the US and Canada mostly in search of better educational opportunities, family reunions, and economic prospects. Temporary Protected Status (TPS) is a key instrument that has made this trend possible in the US. TPS allows individuals from nations that are undergoing armed conflicts, natural disasters, or extraordinary situations to temporarily stay in the United States. This status has been especially important for Belizeans since Hurricane Hattie in 1961 forced major internal relocation. Belizean immigrants frequently participate in family reunion programs in Canada, which is consistent with the country's larger immigration policy that values social integration and family harmony. Belize's major economic sector is services, making up over 60% of the economy. Nearly 50% of migrants came from Guatemala, and the total composition of the migrants was around 50% men and 49% women.
ESI has long been used to both diagnose and treat back pain, although recent evidence, including a 2025 clinical practice guideline published in BMJ, recommends against the use of ESI for chronic back pain due to a lack of efficacy.
=== Chemiluminescence === This technology is based on the luminescence of specific compounds when they bind to explosive particles. Its sensitivity can reach the nanogram (ppb) level. It can be applied in non-electronic formats, such as sprays and test papers, as well as in electronic devices.
October 5–10, 1908 - The rapidly growing, global industry and scientific quest for absolute zero led to the 1st International Congress of Refrigeration held in Paris, France, at the Paris-Sorbonne University, which welcomed over 5,000 participants. January 25, 1909 - From this first Congress, the International Association of Refrigeration was born, formed by delegates from 35 countries. June 21, 1920 - The association was reorganised and officially titled as the International Institute of Refrigeration – IIR (Institut International du Froid – IIF, in French). IIR's status as an international organisation was defined by an International Agreement signed on December 1, 1954, and General Regulations for the Application of the International Agreements signed on November 20, 1956. Since then, the IIR has been operating at its headquarters based in Paris and is now an international organisation for expertise on refrigeration. The institute has continued to run the International Congress of Refrigeration every four years since its inauguration and has now expanded its event portfolio to ten conference series covering a wide variety of refrigeration topics. Working alongside governments, today the IIR remains committed to promoting knowledge on refrigeration for sustainable development, and continues to provide key services to disseminate information on associated technologies to all stakeholders (companies, universities, professionals, etc.).
Sources: en.wikipedia.org
Sanyaa – a type of dried fish prepared by the Newars. Dried shrimp – shrimp that have been sun-dried and shrunk. They are used in many Asian cuisines, imparting a unique umami taste. Shũṭki (শুঁটকি) or Shũṭki machh (শুঁটকি মাছ) – sun-dried fish or shrimp as prepared in Bengali and Assamese cuisine in India and Bangladeshi cuisine in general. In Western India it's colloquially called Bombay Duck. Dried fish is also used in some parts of South India and Sri Lanka Dried shredded squid – a dried, seasoned, seafood product, made from squid or cuttlefish, commonly found in coastal Asian countries, Russia, and Hawaii. Stockfish – unsalted fish, especially cod, dried by cold air and wind on wooden racks on the foreshore, called "hjell".
== Further reading == Allen, Jeannie (6 September 2001). Ultraviolet Radiation: How it Affects Life on Earth. Earth Observatory. NASA, USA. Hockberger, Philip E. (2002). "A History of Ultraviolet Photobiology for Humans, Animals and Microorganisms". Photochemistry and Photobiology. 76 (6): 561–569. doi:10.1562/0031-8655(2002)0760561AHOUPF2.0.CO2. PMID 12511035. S2CID 222100404. Hu, S; Ma, F; Collado-Mesa, F; Kirsner, R. S. (July 2004). "UV radiation, latitude, and melanoma in US Hispanics and blacks". Arch. Dermatol. 140 (7): 819–824. doi:10.1001/archderm.140.7.819. PMID 15262692. Strauss, CEM; Funk, DJ (1991). "Broadly tunable difference-frequency generation of VUV using two-photon resonances in H2 and Kr". Optics Letters. 16 (15): 1192–4. Bibcode:1991OptL...16.1192S. doi:10.1364/ol.16.001192. PMID 19776917.
Ohanin, a minor vespryn protein component specific to this species, causes hypolocomotion and hyperalgesia in experimental mice. It is believed that it contributes to neurotoxicity on the central nervous system of the victim.
== Semantics of changing care: why "flexible" is replacing "intensive" therapy == Over the last two decades, the evidence that better glycemic control (i.e., keeping blood glucose and HbA1c levels as close to normal as possible) reduces the rates of many complications of diabetes has become overwhelming. As a result, diabetes specialists have expended increasing effort to help most people with diabetes achieve blood glucose levels as close to normal as achievable. It takes about the same amount of effort to achieve good glycemic control with a traditional two or three injection regimen as it does with flexible therapy: frequent glucose monitoring, attention to timing and amounts of meals. Many diabetes specialists no longer think of flexible insulin therapy as "intensive" or "special" treatment for a select group of patients but simply as standard care for most patients with type 1 diabetes.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.